March 30, 2022
PAR-22-073 - Innovation Corps (I-Corps ) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)
National Cancer Institute (NCI)
The purpose of this Notice is to inform potential applicants that one more set of cohort dates is scheduled in FY2022 for PAR-22-073, Innovation Corps (I-Corps ) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed). This notice also informs all potential applicants that all required workshops of the program will be conducted virtually. Finally, this notice informs that this cohort is specifically designed for very early-stage Phase I SBIR and STTR (NIH only) awards from NCI such as those funded under Small Business Transition Grant.
The following changes and updates are made to PAR-22-073 (shown in italics) to reflect cohort dates and venue for the third cohort for FY2022 in this FOA.
Currently Reads:
Details for the FY2022 cohorts are given below. All team members accepted to the I-Corps at NIH are required to participate in each of the program events given below. Additional dates will be released by Notice.
Modified to read (in italics):
Details for the additional FY2022cohorts are given below. All team members accepted to the I-Corps at NIH are required to participate in each of the program events given below
| Application Due Date | May 4, 2022 |
| Phone Interview | Week of May 16, 2022 |
| Kick-off/Close-out Venue | Virtual |
| Course Kick-Off | July, 11-14 (Monday to Thursday), 2022 |
|
Weekly Sessions |
Wednesdays, 1:00 to 5:00 PM Eastern Time July 20, 2022 July 27, 2022 August 3, 2022 August 10, 2022 August 17, 2022 August 24, 2022 |
| Course Close-out/Lessons-Learned | August 29-30 (Mon-Tue), 2022 |
| Cohort Size | ~10 - 12 Teams |
Reema Railkar, Ph.D.
National Cancer Institute (NCI)
Phone: 240-276-5720
Email: [email protected]
and Human Services (HHS)
